Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)

SHA:688336 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	369.34	459.49	933.26	1,091	1,614	1,778
Short-Term Investments	-	863.59	344.19	-	-	50
Trading Asset Securities	950.3	910.54	603.87	1,486	752.05	932.63
Cash & Short-Term Investments	1,320	2,234	1,881	2,577	2,366	2,761
Cash Growth	-25.95%	18.73%	-27.00%	8.93%	-14.31%	141.69%
Accounts Receivable	219.03	147.14	133.24	149.35	256.97	102.92
Other Receivables	0.17	0.03	0.2	0.29	0.53	0.5
Receivables	219.2	147.17	133.44	149.65	257.5	103.42
Inventory	204.21	229.6	194.96	227	210.14	225.08
Other Current Assets	1,326	49.64	40.09	32.54	38.09	32.3
Total Current Assets	3,069	2,660	2,250	2,986	2,872	3,122
Property, Plant & Equipment	1,524	1,539	1,562	1,426	1,371	1,287
Long-Term Investments	37.85	1,140	1,020	109.4	122.37	105.59
Goodwill	0.64	0.64	0.64	0.64	0.64	0.64
Other Intangible Assets	216.87	223.96	240.16	195.73	196.55	221.17
Long-Term Deferred Tax Assets	129.15	129.62	145.74	173.43	155.31	103.18
Long-Term Deferred Charges	277.41	228.54	44.44	114.02	97.67	79.48
Other Long-Term Assets	757.15	43.68	42.16	92.76	73.59	35.53
Total Assets	6,013	5,965	5,305	5,098	4,889	4,954
Accounts Payable	28.49	34.96	21.93	15.91	16.27	21.36
Accrued Expenses	55.11	174.93	181.2	56.18	127.71	177.5
Short-Term Debt	-	50.02	50.03	150.1	-	-
Current Income Taxes Payable	-	1.3	1.3	1.2	0.21	0.21
Current Unearned Revenue	6.61	20.2	16.77	19.55	3.25	15.42
Other Current Liabilities	154.31	35.49	36.91	132.15	68.01	65.83
Total Current Liabilities	244.52	316.91	308.14	375.09	215.45	280.32
Long-Term Unearned Revenue	104.49	111.24	118.33	123.79	134.28	153.11
Total Liabilities	349.02	428.15	426.47	498.88	349.73	433.44
Common Stock	616.79	616.79	616.79	616.79	616.21	616.21
Additional Paid-In Capital	2,318	2,310	2,303	2,309	2,301	2,273
Retained Earnings	2,774	2,639	1,985	1,691	1,641	1,623
Comprehensive Income & Other	-9.46	2.44	-8.71	-10.67	-17.33	-9.68
Total Common Equity	5,699	5,568	4,896	4,606	4,542	4,503
Minority Interest	-35.33	-30.76	-17.58	-6.32	-2.46	17.29
Shareholders' Equity	5,664	5,537	4,879	4,600	4,539	4,520
Total Liabilities & Equity	6,013	5,965	5,305	5,098	4,889	4,954
Total Debt	-	50.02	50.03	150.1	-	-
Net Cash (Debt)	1,320	2,184	1,831	2,427	2,366	2,761
Net Cash Growth	-23.81%	19.24%	-24.55%	2.59%	-14.31%	141.69%
Net Cash Per Share	2.14	3.53	2.98	3.94	3.93	4.70
Filing Date Shares Outstanding	622.26	616.79	616.79	616.79	616.21	616.21
Total Common Shares Outstanding	622.26	616.79	616.79	616.79	616.21	616.21
Working Capital	2,825	2,343	1,942	2,611	2,656	2,841
Book Value Per Share	9.16	9.03	7.94	7.47	7.37	7.31
Tangible Book Value	5,481	5,343	4,655	4,409	4,344	4,281
Tangible Book Value Per Share	8.81	8.66	7.55	7.15	7.05	6.95
Buildings	-	626.77	626.77	531.48	531.48	516.17
Machinery	-	1,220	1,196	1,043	1,035	1,007
Construction In Progress	-	749.65	687.81	717.11	572.47	434.54

Source: S&P Global Market Intelligence. Standard template. Financial Sources.